现在位置 >首页 > 进展交流
[Chest发表论文]:ECMO治疗伴有呼吸衰竭的顽固性哮喘发作已关闭评论
ASTHMA: ORIGINAL RESEARCH| VOLUME 163, ISSUE 1, P38-51, JANUARY 2023 Extracorporeal Membrane Oxygenation for Refractory Asthma Exacerbations With Respiratory Failure Jonathan K. Zakrajsek, Sung-Joon Min, P. Michael Ho, et al Chest 2023; 163: 38-51 Published:September 29, 2022 DOI:https://doi.org/10.1016/j.chest.2022.09.029 Background Asthma exacerbations with respiratory failure (AERF) are associated with hospital mortality of 7% to 15%. Extracorpor...
阅读全文
[ICU Management & Practice]: 极高龄的ICU患者:比急性器官功能不全更重要已关闭评论
ICU Management & Practice, Volume 23 - Issue 2, 2023 A Very Old Patient in the ICU: Much More Than an Acute Organ Dysfunction Treating an elderly patient in intensive therapy requires the integration of many components. The purpose of this paper is to promote a comprehensive assessment of the critically ill patient aged 80 or more years. Introduction Ageing of the population combined with a shortage of intensive care unit (ICU) beds results in a deman...
阅读全文
[Chest发表论文]:30分钟自主呼吸试验遗漏很多120分钟自主呼吸试验失败的儿童已关闭评论
CRITICAL CARE: ORIGINAL RESEARCH| VOLUME 163, ISSUE 1, P115-127, JANUARY 2023Download Full Issue A 30-Minute Spontaneous Breathing Trial Misses Many Children Who Go On to Fail a 120-Minute Spontaneous Breathing Trial Kelby E. Knox, Justin C. Hotz, Christopher J.L. Newth, et al Chest 2023; 163: 115-127 Published:August 26, 2022 DOI:https://doi.org/10.1016/j.chest.2022.08.2212 Background The optimal length of spontaneous breathing trials (SB...
阅读全文
[Chest发表论文]:吸入妥布霉素治疗伴随铜绿假单胞菌感染的支气管扩张成年患者的双盲随机安慰剂对照3期临床试验已关闭评论
CHEST INFECTIONS: ORIGINAL RESEARCH| VOLUME 163, ISSUE 1, P64-76, JANUARY 2023Download Full Issue A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection Wei-jie Guan, Jin-fu Xu, Hong Luo, et al Chest 2023; 163: 64-67 Published:July 18, 2022 DOI:https://doi.org/10.1016/j.chest.2022.07.007 Background Few large-scale studies hav...
阅读全文
[ICU Management & Practice]: 肝素诱导血小板减少已关闭评论
ICU Management & Practice, Volume 23 - Issue 2, 2023 Heparin-Induced Thrombocytopaenia Heparin-induced thrombocytopaenia (HIT) is an immune complication of heparin therapy. This review discusses the pathophysiology, incidence, clinical manifestations, diagnostic approach, and management of patients with HIT. Pathophysiology HIT is an immune complication of heparin therapy caused by IgG antibodies to complexes of platelet factor 4 (PF4) and heparin. Th...
阅读全文
[Chest发表论文]:美国急性呼吸功能衰竭患者纤维支气管镜使用的时间趋势与差异已关闭评论
CRITICAL CARE: ORIGINAL RESEARCH| VOLUME 163, ISSUE 1, P128-138, JANUARY 2023Download Full Issue Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United States Max T. Wayne, Thomas S. Valley, Douglas A. Arenberg, et al Chest 2023; 163: 128-138 Published:August 22, 2022 DOI:https://doi.org/10.1016/j.chest.2022.08.2210 Background National data on bronchoscopy for the evaluation of acute respiratory failure are lacking,...
阅读全文
[Chest发表论文]:静脉大剂量维生素B12治疗感染性休克已关闭评论
CRITICAL CARE: ORIGINAL RESEARCH| VOLUME 163, ISSUE 2, P303-312, FEBRUARY 2023Download Full Issue High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial) Jayshil J. Patel, Rodney Willoughby, Jennifer Peterson, et al Chest 2023; 163: 303-312 Published:September 26, 2022 DOI:https://doi.org/10.1016...
阅读全文
[Chest发表论文]:皮质激素对社区获得性肺炎病死率和临床治愈率的影响已关闭评论
CHEST INFECTIONS: ORIGINAL RESEARCH| VOLUME 163, ISSUE 3, P484-497, MARCH 2023Download Full Issue Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials Naveed Saleem, Adarsh Kulkarni, Timothy Arthur Chandos Snow, et al Chest 2023; 163: 484-497 Published:September 07, 2022 DOI:https://doi.org/10.1016/j.chest.2022.08.2229 Background Comm...
阅读全文
[ICU Management & Practice]: ICU中应使用何种升压药物和强心药物已关闭评论
ICU Management & Practice, Volume 23 - Issue 2, 2023 Which Vasopressors and Inotropes to Use in the Intensive Care Unit Vasopressors and inotropes are frequently used in intensive care units. With a special focus on recent studies, this article summarises the key messages in the management of patients requiring inotropes and vasopressors. Introduction Cardiac output (CO) is a key determinant of oxygen delivery. Low cardiac output syndrome (LCOS) cause...
阅读全文
[Chest发表论文]:胺碘酮与利多卡因治疗院内心跳骤停的比较已关闭评论
CRITICAL CARE: ORIGINAL RESEARCH| VOLUME 163, ISSUE 5, P1109-1119, MAY 2023Download Full Issue Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest Deborah Wagner, S.L. Kronick, H. Nawer, et al Chest 2023; 153: 1109-1119 Published:November 01, 2022 DOI:https://doi.org/10.1016/j.chest.2022.10.024 Background American Heart Association Advanced Cardiac Life Support (ACLS) guidelines support the...
阅读全文
×
腾讯微博